0

    540359

    PARMAX

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Parmax Pharma Limited Share Price Today

    Investment Returns

    Over 1 Month 70.00% Over 3 Months 198.46% Over 6 Months 136.38% Over 1 Year 126.04%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Parmax Pharma Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 35.60
    • P/E Ratio (TTM) -8.39
    • Beta 0.18
    • Book Value / share -18.33
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.58
    info icon alternate text

    Parmax Pharma Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 3.31
    Operating Expense 5.61
    Net Profit -0.58
    Net Profit Margin (%) -17.52
    Earnings Per Share (EPS) -1.56
    EBITDA -1.52
    Effective Tax Rate (%) 74.44
    Particulars DEC 2025 (Values in Cr)
    Revenue 4.33
    Operating Expense 5.07
    Net Profit -0.73
    Net Profit Margin (%) -16.85
    Earnings Per Share (EPS) -1.96
    EBITDA -0.17
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 2.53
    Operating Expense 4.62
    Net Profit -2.08
    Net Profit Margin (%) -82.21
    Earnings Per Share (EPS) -5.56
    EBITDA -1.58
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.94
    Operating Expense 2.71
    Net Profit -0.76
    Net Profit Margin (%) -39.17
    Earnings Per Share (EPS) -2.04
    EBITDA -0.24
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 4.83
    Operating Expense 5.45
    Net Profit -1.49
    Net Profit Margin (%) -30.84
    Earnings Per Share (EPS) -4.00
    EBITDA -1.74
    Effective Tax Rate (%) 16.66
    Particulars MAR 2026 (Values in Cr)
    Revenue 12.11
    Operating Expense 18.00
    Net Profit -4.16
    Net Profit Margin (%) -34.35
    Earnings Per Share (EPS) -11.12
    EBITDA -3.59
    Effective Tax Rate (%) 28.88
    Particulars MAR 2025 (Values in Cr)
    Revenue 28.20
    Operating Expense 29.57
    Net Profit -2.09
    Net Profit Margin (%) -7.41
    Earnings Per Share (EPS) -5.60
    EBITDA -0.78
    Effective Tax Rate (%) 12.50
    Particulars MAR 2024 (Values in Cr)
    Revenue 11.05
    Operating Expense 16.76
    Net Profit -5.75
    Net Profit Margin (%) -52.03
    Earnings Per Share (EPS) -15.37
    EBITDA -3.33
    Effective Tax Rate (%) -1.59
    Particulars MAR 2023 (Values in Cr)
    Revenue 15.42
    Operating Expense 15.42
    Net Profit -0.10
    Net Profit Margin (%) -0.64
    Earnings Per Share (EPS) -0.28
    EBITDA 2.30
    Effective Tax Rate (%) 299.99
    Particulars MAR 2022 (Values in Cr)
    Revenue 18.25
    Operating Expense 18.01
    Net Profit 0.14
    Net Profit Margin (%) 0.76
    Earnings Per Share (EPS) 0.38
    EBITDA 2.62
    Effective Tax Rate (%) 53.33
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share -4.47
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 1.06
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 0.24
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.90
    EBITDA Margin -30.05
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 13.16
    ROE % -1.69
    ROCE % 3.76
    Total Debt to Total Equity 0.89
    EBITDA Margin 14.85
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 13.39
    ROE % 2.38
    ROCE % 6.04
    Total Debt to Total Equity 0.94
    EBITDA Margin 14.41
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 13.07
    ROE % 13.79
    ROCE % 14.26
    Total Debt to Total Equity 1.02
    EBITDA Margin 13.44
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 18.75
    Total Liabilities 18.75
    Total Equity -1.98
    Share Outstanding 0
    Price to Book Ratio -9.45
    Return on Assets (%) -11.16
    Return on Capital (%) -36.64
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 15.33
    Total Liabilities 15.33
    Total Equity 0.10
    Share Outstanding 0
    Price to Book Ratio 118.67
    Return on Assets (%) -37.51
    Return on Capital (%) -95.65
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.40
    Total Assets 17.61
    Total Liabilities 17.61
    Total Equity 5.85
    Share Outstanding 0
    Price to Book Ratio 2.31
    Return on Assets (%) -0.59
    Return on Capital (%) -1.01
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.05
    Total Assets 17.97
    Total Liabilities 17.97
    Total Equity 5.95
    Share Outstanding 0
    Price to Book Ratio 3.05
    Return on Assets (%) 0.78
    Return on Capital (%) 1.35
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.54
    Total Assets 22.72
    Total Liabilities 22.72
    Total Equity 5.81
    Share Outstanding 0
    Price to Book Ratio 2.72
    Return on Assets (%) 3.31
    Return on Capital (%) 6.7
    Particulars MAR 2025 (Values in Cr)
    Net Income -2.39
    Cash from Operations -0.95
    Cash from Investing -0.70
    Cash from Financing 1.39
    Net change in Cash -0.26
    Free Cash Flow -0.25
    Particulars MAR 2024 (Values in Cr)
    Net Income -5.65
    Cash from Operations -0.19
    Cash from Investing -1.58
    Cash from Financing 1.42
    Net change in Cash -0.35
    Free Cash Flow 1.39
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.04
    Cash from Operations 0.33
    Cash from Investing -0.93
    Cash from Financing -0.04
    Net change in Cash -0.64
    Free Cash Flow 1.26
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.30
    Cash from Operations 0.74
    Cash from Investing -1.53
    Cash from Financing -0.91
    Net change in Cash -1.69
    Free Cash Flow 2.28
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.20
    Cash from Operations 3.52
    Cash from Investing -3.14
    Cash from Financing 0.39
    Net change in Cash 0.77
    Free Cash Flow 6.67
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD. 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 411.65 18.16 2.97 1211.53 256.40 415.70
    GLAXOSMITHKLINE PHARMACEUTICAL 2435.50 42.88 18.19 41258.84 2088.00 3301.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD. 521.10 56.34 4.78 5526.59 118.35 552.90

    Parmax Pharma Limited shareholding pattern

    Holding
    69.19%
    30.8%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Parmax Pharma Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    95.16 1.99 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 89.70
    • 26 Days 73.30
    • 10 Days 85.60
    • 50 Days 61.10
    • 12 Days 83.90
    • 100 Days 49.80
    • 20 Days 77.50
    • 200 Days 43.00
    91.48 PIVOT
    First Support 91.48 First Resistance 91.48 Second Support 91.48 Second Resistance 91.48 Third Support 91.48 Third Resistance 91.48
    RSI 93.53 ADX 93.76 MACD 10.60 Williams % R 0.00 Commodity Channel Index (CCI) 132.14
    Date 2026-07-10 Week 5653.00 Same Day 10735.00 Month 5636.00
    1 Year 0.19 3 Year 0.20
    Over 1 Month
    70.00% down
    Over 1 Year
    126.04% down
    Over 3 Months
    198.46% down
    Over 3 Years
    46.05% down
    Over 6 Months
    136.38% down
    Over 5 Years
    11.53% down

    Parmax Pharma Limited Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Parmax Pharma Ltd?

    Answer Field

    Parmax Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 95.16 as on Jul 14 2026 03:15 PM.

    What is the Market Cap of Parmax Pharma Ltd Share?

    Answer Field

    The market cap of Parmax Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 35.60 as on Jul 14 2026 03:15 PM.

    What is the 52 Week High and Low of Parmax Pharma Ltd?

    Answer Field

    The 52 Week High and Low of Parmax Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 95.16 and ₹ 22.60.

    What is 1 year return for Parmax Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been 138.86%.

    What is the P/E Ratio of Parmax Pharma Ltd Share?

    Answer Field

    As on Jul 14 2026 03:15 PM the price-to-earnings (PE) ratio for Parmax Pharma Ltd share is -8.39.

    What is the PB ratio of Parmax Pharma Ltd Share?

    Answer Field

    As on Jul 14 2026 03:15 PM, the price-to-book (PB) ratio for Parmax Pharma Ltd share is -18.33.

    How to Buy Parmax Pharma Ltd Share?

    Answer Field

    You can trade in Parmax Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Parmax Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Parmax Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Parmax Pharma Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |